Daniel A. Geselowitz, Ph.D. has expertise in many areas of chemistry, biotechnology, and pharmaceuticals. He has 20 years of experience preparing and prosecuting U.S. patent applications directed to complex technologies, and has been registered as a U.S. patent agent before the U.S. Patent and Trademark Office since 1998.
Daniel received his Ph.D. in Chemistry from Stanford University in 1982 and studied under Professor Henry Taube, who was awarded the 1983 Nobel Prize in Chemistry while at Stanford University for his contributions to the understanding of electron transfer in chemical reactions.
Daniel worked in industrial and academic settings and was a Biotechnology Fellow at the National Cancer Institute of the world-renowned National Institutes of Health (NIH) from 1989 to 1993. He also worked at the Clinical Center of the NIH from 1993 to 1996 and as a consultant to Atlantic Pharmaceuticals from 1996 to 1997. Daniel is a member of the American Chemical Society.
Daniel has been in his current position since 2001.
